Bach P, Robinson S, Sutherland C, Brar R Innovative strategies to support physical distancing among individuals with active addiction Lancet Psychiatry PubMed

Brar R, Fairbairn N, Sutherland C, Nolan S Use of a novel prescribing approach for the treatment of opioid use disorder: buprenorphine/naloxone micro-dosing - a case series Drug Alcohol Rev PubMed

Olding M, Ivsins A, Mayer S, Betsos A, Boyd J, Sutherland C, Culbertson C, Kerr T, McNeil R A low-barrier and comprehensive community-based harm-reduction site in Vancouver, Canada Am J Public Health PubMed

Caulfield MDG, Brar R, Sutherland C, Nolan S Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach BMJ Case Rep PubMed

Wilson T, Brar R, Sutherland C, Nolan S Use of a primary care and pharmacy-based model for the delivery of injectable opioid agonist treatment for severe opioid use disorder: a case report CMAJ PubMed

Giang V, Brar R, Sutherland C, Nolan S HIV treatment initiation and retention among individuals initiated on injectable opioid agonist therapy for severe opioid use disorder: a case series J Addict Med PubMed